Marc Beer

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.

Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France.

Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.

Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA.

Renovia, Inc. engages in the development of sensor technologies combined with a digital health platform. The firm allows visualization and treatment of weakened pelvic floor muscles in real time, while collecting actionable compliance and progress data on women?s pelvic health. The company was founded by Marc Beer, Ramon Iglesias, Yolanda Lori? and James Frigge in August 2016 and is headquartered in Boston, MA.

Origami Surgical, Inc. engages in the development of a patented device that facilitates suturing during robotic surgery procedures. It offers StitchKit a pre-loaded suture delivery canister designed to facilitate suturing in robotic-assisted minimally invasive surgery. The company was founded by Patrick Culligan in 2020 and is headquartered in Madison, NJ.

Part of Biote Corp., Biote Medical LLC is a hormone optimization company based in Irving, TX. Biote Medical offers bioidentical hormone replacement pellet therapy and supporting supplements to both men and women. The company has partnered with over 5,500 medical providers to educate practitioners on the scientific evidence of the roles of hormones and supplements to support improved health and responsible treatment of patients. The company was founded in 2009 by Gary S. Donovitz, and Terry S. Weber has been the CEO of the company since 2018. Biote Medical was acquired by Haymaker Acquisition Corp. III on May 26, 2022 for $580.97 million.

Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation.

LumeNXT LLC is a surgical device company that specializes in non-tethered LED illumination technology. LumeNXT is based in Boston, MA. The private company's proprietary technology is battery-driven and offers several advantages over current options available in the market. The company was founded by Marc D. Beer and is currently led by CEO Chris Doody.

Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA.